Ben-Chetrit E, Navon P
Department of Medicine, Hadassah University Hospital, Jerusalem, POB12000, Israel.
Clin Exp Rheumatol. 2003 Jul-Aug;21(4 Suppl 30):S38-40.
A young patient with familial Mediterranean fever (FMF) developed leukopenia each time she took colchicine. However, when she discontinued the drug the white cell and the platelets counts increased but she experienced FMF attacks. Later it was found that the patient also had concomitant cytomegalovirus (CMV) infection. This complex situation posed several diagnostic and therapeutic issues concerning the real cause for the leukopenia and the possible approach to take in such conditions. We propose that when an essential drug (such as colchicine for FMF) causes leukopenia, one should look for concurrent CMV or another viral infection. If there is no such infection, it is suggested that the mechanism leading to leukopenia be clarified. In the case of bone marrow suppression, colchicine should be continued with injections of G-CSF, whereas if the bone marrow is hypercellular it is suggested to use steroids and colchicine concomitantly.
一名患有家族性地中海热(FMF)的年轻患者每次服用秋水仙碱时都会出现白细胞减少。然而,当她停药时,白细胞和血小板计数会增加,但她会经历FMF发作。后来发现该患者还伴有巨细胞病毒(CMV)感染。这种复杂情况带来了几个关于白细胞减少的真正原因以及在这种情况下可能采取的方法的诊断和治疗问题。我们建议,当一种必需药物(如用于FMF的秋水仙碱)导致白细胞减少时,应寻找同时存在的CMV或其他病毒感染。如果没有这种感染,建议阐明导致白细胞减少的机制。在骨髓抑制的情况下,秋水仙碱应继续使用并注射粒细胞集落刺激因子(G-CSF),而如果骨髓细胞增多,则建议同时使用类固醇和秋水仙碱。